Clinical Trial: GliomaAI-GBM: MRI-Based Detection of IDH Wildtype Glioblastoma

U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673692) titled 'GliomaAI-GBM: MRI-Based Detection of IDH Wildtype Glioblastoma' on June 13.

Brief Summary: The goal of this observational study is to learn whether an artificial intelligence system called GliomaAI-GBM can help detect a specific molecular type of brain tumour called IDH wildtype glioblastoma using routine MRI scans. The study uses previously collected and fully anonymised MRI data from 1,372 patients from 13 institutions in the Cancer Imaging Archive (TCIA).

The main questions it aims to answer are:

* How accurately can GliomaAI-GBM identify IDH wildtype glioblastoma from MRI scans?

* How well does the system perform across data ...